-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on MiMedx Group, Lowers Price Target to $8

Benzinga·02/17/2026 15:28:22
Listen to the news
Cantor Fitzgerald analyst Sarah James maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and lowers the price target from $12 to $8.